bioRxiv · 10.1101/396929
Direct estimation of HDL-mediated cholesterol efflux capacity from serum
Abstract
High-density lipoprotein mediated cholesterol efflux capacity (HDL-CEC) is a functional attribute that may have a protective role in atherogenesis. However, the estimation of HDL-CEC is based on in vitro cell assays that are laborious and hamper large-scale phenotyping. Here, we present a cost-effective high-throughput nuclear magnetic resonance (NMR) spectroscopy method to estimate HDL-CEC directly from serum. We applied the new method in a population-based study of 7,603 individuals including 574 who developed incident coronary heart disease (CHD) during 15 years of follow-up, making this the largest quantitative study for HDL-CEC. As estimated by NMR-spectroscopy, a 1-SD higher HDL-CEC was associated with a lower risk of incident CHD (hazards ratio 0.86; 95%CI 0.79-0.93, adjusted for traditional risk factors and HDL-C). These findings are consistent with published associations based on in vitro cell assays. These corroborative large-scale findings provide further support for a potential protective role of HDL-CEC in CHD, and substantiate this new method and its future applications.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Kuusisto, S., Holmes, M. V., Ohukainen, P., Kangas, A. J., Karsikas, M., Tiainen, M., Perola, M., Salomaa, V., Kettunen, J., Ala-Korpela, M.. 2018-08-24. Direct estimation of HDL-mediated cholesterol efflux capacity from serum. https://doi.org/10.1101/396929
Cite the original work for its findings. Save a collection to share your selection of sources.